This is a prospective randomized controlled trail to assess early urinary continence recovery rates after robotic assisted radical prostatectomy when a posterior rhabdosphincter reconstruction is performed or not. A hundred forty-six patients with clinically localized and histological confirmed prostate cancer will be enrolled. Continence recovery is defined in the present study as declared urinary continence (absence of incontinence episodes) in the physician interview as no pad use. Continence rates will be explored also by EPIC, ICIQ-SF, IPSS questionnaires 1, 6 and 12 months after the procedure. The sexual function as the secondary objective will be assessed by SHIM questionnaire.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Enrollment
156
To suture the Denonvilliers fascia and bladder to the median dorsal raphe according to Rocco technique.
Standard technique with a running suture to perform the urethrovesical anastomosis
Hospital Universitari Vall d'Hebron
Barcelona, Spain
Number of patients using 0-1 PAD/d (EPIC-26 question_5) at 1st monthNumber of patients using 0-1 PAD/d (EPIC-26 question_5) at 1st month
Absence of urinary incontinence (number of PADs/d)
Time frame: 1 month after surgery
Number of patients using 0-1 PAD/d (EPIC-26 question_5) at 6th month
Absence of urinary incontinence (number of PADs/d)
Time frame: 6 months after surgery
early urinary recovery quantification in Grams (PAD-test 24h)
PAD-test during the first month after surgery
Time frame: one day before catheter removal, 2 weeks before and 1 month before
Number of patients using 0-1 PAD/d (EPIC-26 question_5) at 12th month
Absence of urinary incontinence (number of PADs/d)
Time frame: 12 months after surgery
Erectile function
SHIM assessment
Time frame: 1, 6 and 12 months
Quality of life I: urinary and bowel function
EPIC-26 urinary and digestive function
Time frame: 1, 6 and 12 months
Quality of life II: urinary function
ICIQ-SF assessment of urinary function
Time frame: 1, 6 and 12 months
Quality of life III: urinary function
IPSS assessment of urinary function
Time frame: 1, 6 and 12 months
Oncological outcome: Biochemical free-recurrence status
serum PSA assessment. Biochemical free-recurrence status = PSA \<0.2
Time frame: 1, 6 and 12 months
Anatomopathological parameters: Surgical margins
Surgery margins in prostatectomy specimens
Time frame: 1 month
Anatomopathological parameters: pTNM classification
Pathological pTNM in prostatectomy specimens
Time frame: 1 month
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.